The growth of diagnostics industry has been spurred by a continuing need of seeking fast, accurate and cheaper diagnostics tests. The technological breakthroughs with an increasing trend towards the automated platforms are driving the growth of molecular diagnostics industry, however, high amounts of investment needed for developing such systems remains a constraint for manufacturers.
Frost & Sullivan finds that technologies like Polymerase Chain Reaction (PCR), DNA Microarrays with emerging ones like Transrenal DNA, Nano-JETA platforms are driving the growth of Molecular Diagnostics industry with key applications in the area of infectious diseases and oncology.
If you are interested in a virtual brochure, which provides manufacturers, end users, and other industry participants with an overview of the latest analysis of the Molecular Diagnostics – Industry Assessment, then send an e-mail to Melina Trevino - Corporate Communications at melina.trevino[.]frost.com with the following information: your full name, company name, title, telephone number, e-mail address, city, state, and country. We will send you the information via email upon receipt of the above information.
"A continuing need for real-time, faster, more sensitive, less labour-intensive and hence, more cost-effective molecular diagnostic solutions that can replace or complement traditional methods is driving the growth of this industry," notes Frost & Sullivan senior research analyst Sachin Thukral.
The development of automated and highly breakthrough systems for molecular diagnostics helps in decreasing demand for labor and lowering the cost per assay, at the same time enabling laboratories to process higher volumes of samples.
However, one of the biggest challenges to be addressed by Molecular Diagnostics Industry is of automated sample handling where systems need to be optimized and developed for high-volume production capabilities.
“Such high-volume production capabilities certainly ask for significant amounts of investment and a lot of players in this industry working on such platforms find it quite challenging to invest such amounts of money," explains Thukral.
The manufacturers need to aggressively promote the advantages of such systems to the industry be it in terms of speed, accuracy, or cost. This will help them in attracting funding from government bodies, venture capitalists or other funding agencies.
Molecular Diagnostics – Industry Assessment is part of the Technical Insights – Healthcare Subscription, which also includes research in the following markets: In-Vitro Diagnostics, European Advances in Nucleic-Acid Purification and Amplification Technologies, Advances in Point-of-care Technologies, Emerging Technologies in Lab-on-a-chip: Microarrays and Biochips. All research included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants. Interviews are available to the press.
Technical Insights is an international technology analysis business that produces a variety of technical news alerts, newsletters, and research services.
Frost & Sullivan, a global growth consulting company, has been partnering with clients to support the development of innovative strategies for more than 40 years. The company's industry expertise integrates growth consulting, growth partnership services, and corporate management training to identify and develop opportunities. Frost & Sullivan serves an extensive clientele that includes Global 1000 companies, emerging companies, and the investment community by providing comprehensive industry coverage that reflects a unique global perspective and combines ongoing analysis of markets, technologies, econometrics, and demographics.